PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'MIGAL Research Institute in the Galilee, Kiryat Shmona, Israel; Tel-Hai Academic College, Upper Galilee, Israel.\', \'MIGAL Research Institute in the Galilee, Kiryat Shmona, Israel.\', \'MigVax Ltd., Israel.\', \'MIGAL Research Institute in the Galilee, Kiryat Shmona, Israel; Tel-Hai Academic College, Upper Galilee, Israel. Electronic address: Ehudsha@migal.org.il.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0264-410X(22)00050-010.1016/j.vaccine.2022.01.025
?:doi
?:hasPublicationType
?:journal
  • Vaccine
is ?:pmid of
?:pmid
?:pmid
  • 35078662
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.863
?:rankingScore_hIndex
  • 159
is ?:relation_isRelatedTo_publication of
?:title
  • Oral subunit SARS-CoV-2 vaccine induces systemic neutralizing IgG, IgA and cellular immune responses and can boost neutralizing antibody responses primed by an injected vaccine.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35078662>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35078662>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all